Quick Takeaways
- MILLENNIUM MANAGEMENT LLC filed SCHEDULE 13G for Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share (AVTX).
- Disclosed ownership: 5%.
- Date of event: 17 Feb 2026.
MILLENNIUM MANAGEMENT LLC - 17 Feb 2026 SCHEDULE 13G Report for Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share (AVTX)
- Filing Manager
- MILLENNIUM MANAGEMENT LLC
- Reporting Manager
- Millennium Management LLC
- Symbol
- AVTX
- Shares outstanding
- 18,688,580 shares
- Disclosed Ownership
- 934,429 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G
- Filing time
- 24 Feb 2026, 16:48:09 UTC
- Date of event
- 17 Feb 2026
- Previous filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"MILLENNIUM MANAGEMENT LLC disclosed 5% ownership in Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share (AVTX) on 17 Feb 2026."
What Changed
- Previous schedule filing date: 17 Feb 2026.
- Current filing was accepted on 24 Feb 2026, 16:48.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Millennium Management LLC | 5% | 934,429 | 0 | 934,429 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Group Management LLC | 5% | 934,429 | 0 | 934,429 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Israel A. Englander | 5% | 934,429 | 0 | 934,429 | /s/ Israel A. Englander | Israel A. Englander |